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Abstract 1 
 2 
Physiologic mechanical stress stimulates expression of chondrogenic genes, such as multifunctional 3 
growth factor CYR61/CTGF/NOV (CCN) 2 and α1(II) collagen (COL2A1), and maintains cartilage 4 
homeostasis. In our previous studies, cyclic tensile strain (CTS) induces nuclear translocation of 5 
transforming growth factor (TGF)-β receptor-regulated Smad2/3 and the master chondrogenic 6 
transcription factor Sry-type HMG box (SOX) 9. However, the precise mechanism of stretch-mediated 7 
Smad activation remains unclear in transcriptional regulation of CCN2 and COL2A1. Here we 8 
hypothesized that CTS may induce TGF-β1 release and stimulate Smad-dependent chondrogenic gene 9 
expression in human chondrocytic SW1353 cells. Uni-axial CTS (0.5 Hz, 5% strain) stimulated gene 10 
expression of CCN2 and COL2A1 in SW1353 cells, and induced TGF-β1 secretion. CCN2 synthesis and 11 
nuclear translocalization of Smad2/3 and SOX9 were stimulated by CTS. In addition, CTS increased the 12 
complex formation between phosphorylated Smad2/3 and SOX9. The CCN2 promoter activity was 13 
cooperatively enhanced by CTS and Smad3 in luciferase reporter assay. Chromatin immunoprecipitation 14 
revealed that CTS increased Smad2/3 interaction with the CCN2 promoter and the COL2A1 enhancer. 15 
Our results suggest that CTS epigenetically stimulates CCN2 transcription via TGF-β1 release associated 16 
with Smad2/3 activation and enhances COL2A1 expression through the complex formation between 17 
SOX9 and Smad2/3. 18 
 19 
20 
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Introduction 1 
Articular cartilage is subjected to various biomechanical stresses such as static/dynamic loads, 2 
compressive force, shear strain, hydrostatic pressure, fluid flow, and osmotic stress (Wong et al., 2010). 3 
During normal daily activity, the knee joint cartilage compresses 2-5% of the overall thickness, and 4 
intense exercise adds another 2-3% compression of the cartilage (Eckstein et al., 2006). Tensile stiffness 5 
of articular cartilage plays an essential role even in compressive properties by increasing transient fluid 6 
pressures during physiological loading [Charlebois et al., 2004]. Physiologic mechanical stress stimulates 7 
chondrogenic gene expression and maintains cartilage homeostasis. On the other hand, repetitive excess 8 
mechanical stress can alter cartilaginous composition and metabolism, leading to osteoarthritis. 9 
Abnormal joint loading inhibits extracellular matrix (ECM) synthesis of cartilage via induction of 10 
proteolytic enzymes including matrix metalloproteinases (MMPs) and a disintegrin and 11 
metalloproteinase with thrombospondin motifs (ADAMTS) (Patwari et al., 2003). We have previously 12 
reported that immoderate cyclic tensile strain (CTS, 0.5 Hz, 10% strain) induces expression of catabolic 13 
factors, such as MMP-13 and ADAMTS-4/5/9, and inhibits expression of cartilage-specific ECM 14 
molecule α1(II) collagen (COL2A1) in human chondrocytic SW1353 cells (Tetsunaga et al., 2011). In 15 
addition, excessive CTS (10% strain) stimulates expression of MMP-3/13 and ADAMTS-5 in human 16 
articular chondrocytes (Saito et al., 2013). On the other hand, appropriate stretching force (5-6% strain) 17 
increases expression of anabolic factors, such as COL2A1 and multifunctional growth factor 18 
CYR61/CTGF/NOV (CCN) 2, in human fibrochondrocytes derived from the inner meniscus and 19 
chondrocytic HCS-2/8 cells (Nishida et al., 2008; Kanazawa et al., 2012; Furumatsu et al., 2012). 20 
However, mechanical stretch-mediated transcriptional regulation of chondroprotective genes remains 21 
unclear. 22 
CCN2 has a multifunctional role in cellular proliferation, differentiation, ECM synthesis, and 23 
tissue regeneration (Kubota and Takigawa, 2007). Ccn2-null mice are perinatal lethal, showing severe 24 
chondrodisplasia characterized by deficient ECM production, impaired endochondral ossification, and 25 
reduced growth plate angiogenesis (Ivkovic et al., 2003). These phenotypes indicate that CCN2 plays an 26 
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essential role in chondrogenesis and skeletal development. In addition, transforming growth factor 1 
(TGF)-β, which organizes chondrogenic differentiation, and its receptor-regulated Smad2/3 are 2 
considered as central inducers of CCN2 expression via Smad2/3 association with the Smad-binding 3 
element (SBE), which contains GTCT and its complement AGAC motifs, on the CCN2 promoter .10,12 4 
Mechanical stretch also modulates expression of CCN2 and TGF-β in ligament-derived cells (Kim et al., 5 
2002). In rat endplate-derived chondrocytes, cyclic strain enhances release of TGF-β1 in the conditioned 6 
medium, and the optimum TGF-β1 secretion is observed under a stretching frequency of 0.5 Hz (Xu et 7 
al., 2011). Dynamic compression (0.5 Hz, 20-40 kPa, 5-15 min) promotes the phosphorylation 8 
(activation) of TGF-β-related Smad2/3, but does not activate that of bone morphogenetic 9 
protein-regulated Smad1/5/8, in three-dimensional-cultured chondrocytes derived from mouse embryonic 10 
costal cartilage (Bougault et al., 2012). We have previously demonstrated that CTS (0.5 Hz, 5% strain) 11 
induces the nuclear translocation of phosphorylated Smad2/3 and enhances Smad3-dependent CCN2 12 
expression in inner meniscus cells (Furumatsu et al., 2012). However, the precise mechanism of 13 
stretch-mediated Smad activation is not fully elucidated. Here we hypothesized that physiological 14 
stretching stimulus may induce immediate TGF-β1 release, followed by Smad2/3 activation in 15 
chondrocytic cells. 16 
Smad3 directly associates with Sry-type HMG box (SOX) 9, and also activates 17 
SOX9-dependent transcription on chromatin during chondrogenesis (Furumatsu et al., 2005A). SOX9, 18 
which encodes a high-mobility group DNA-binding domain, has been identified as the master 19 
transcription factor in chondrogenesis. SOX9 regulates the expression of its target genes through the 20 
association with the SOX9-binding sequences (WWCAAWG) on promoters or enhancers of 21 
cartilage-specific genes, such as COL2A1 and aggrecan (Bell et al., 1997). During the epigenetic 22 
regulation of chondrogenesis, SOX9-dependent COL2A1 expression is synergistically activated by 23 
co-activator p300, which has an intrinsic histone acetyltransferase activity, and Smad3 (Furumatsu et al., 24 
2005B, 2009). In addition, the nuclear translocalization of phosphorylated SOX9 is increased by CTS 25 
treatment (0.5 Hz, 5% strain) in inner meniscus cells (Kanazawa et al., 2012). These findings prompted 26 
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us to investigate the mechanical stretch-induced transcriptional complex formation between Smad2/3 and 1 
SOX9 on chromatin. 2 
In the present study, we examined expression of CCN2 and COL2A1 responding to mechanical 3 
stretch in chondrocytic SW1353 cells, and further investigated the mechanism of stretch-mediated 4 
Smad2/3 activation and the interplay between Smad2/3 and their target gene expression. 5 
 6 
Methods 7 
Cells and cell culture: Institutional Review Board approval was obtained before all experimental studies. 8 
A human chondrosarcoma cell line (SW1353), well-characterized cells for investigating chondrocytic 9 
behaviors during chondrogenesis, was used as chondrocytic cells that maintain a sufficient potential to 10 
induce SOX9-regulated chondrogenesis (Tsuda et al., 2003; Barksby et al., 2006; Furumatsu et al., 11 
2005A and 2010). SW1353 cells were maintained with Dulbecco’s modified Eagle’s medium (DMEM, 12 
Wako, Osaka, Japan) containing 10% fetal bovine serum (FBS, HyClone, South Logan, UT), 1% 13 
penicillin/streptomycin (Sigma, St. Louis, MO), and 0.17 mM ascorbate (Sigma). 14 
Quantitative real-time PCR: RNA samples were obtained from cultured SW1353 cells. Total RNAs were 15 
isolated using ISOGEN reagent (Nippon Gene, Toyama, Japan). RNA samples (500 ng) were 16 
reverse-transcribed with ReverTra Ace (Toyobo, Osaka, Japan). The cDNAs underwent PCR 17 
amplification in the presence of specific primers for CCN2, COL2A1, SOX9, and 18 
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) (Tetsunaga et al., 2009; Furumatsu et al., 2011). 19 
Quantitative real-time PCR analyses were performed using a LightCycler ST-300 instrument (Roche 20 
Diagnostics, Mannheim, Germany) and FastStart DNA Master SYBR Green I kit (Roche Diagnostics) 21 
according to the manufacturer’s protocol. The PCR mixture consisted of 1 x STBR Green PCR Master 22 
Mix, which included DNA polymerase, SYBR Green I dye, dNTPs, PCR buffer, 10 pmol of forward and 23 
reverse primers, cDNA samples, in a total volume of 15μL. Real-time PCR validation was carried out 24 
using the 2-ΔΔCt method. The cycle number at which the amount of the amplified gene of interest reached 25 
a fixed threshold was determined. Amplification data of G3PDH were used for normalization. Relative 26 
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mRNA levels were normalized with the level of unstretched or untreated cells. 1 
Cyclic tensile strain (CTS): Polydimethylsiloxane stretch chambers (STREX, Osaka, Japan) were coated 2 
with 100 μg/mL of rat tail type I collagen (BD Biosciences, Bedford, MA). SW1353 cells were seeded 3 
onto stretch chambers, having a culture surface of 1, 4, or 10 cm2, at 15,000 cells/cm2. Cells were 4 
incubated on chambers for 24 h in FBS-supplemented DMEM, followed by 12 h in serum-free DMEM 5 
before stretching. Uni-axial CTS (0.5 Hz, 5% strain) was applied using a STB-140 system (STREX) for 6 
an indicated duration. Unstretched cells on chambers were used as controls. Cells, RNAs, proteins, and 7 
conditioned media were immediately collected after stretching experiments. 8 
Immunohistochemistry: The distribution of CCN2 protein in SW1353 cells was assessed by 9 
immunohistochemical analyses using a goat anti-CCN2 antibody (R&D Systems, Minneapolis, MN, 10 
working dilution 1:100 for 1 h incubation) as described (Miyake et al., 2011). Cells seeded on type I 11 
collagen-coated chambers were fixed with 4% paraformaldehyde solutions after CTS treatments. The 12 
localization of Smad2/3, SOX9, and TGF-β1 in SW1353 cells was assessed by rabbit anti-Smad2/3 13 
antibody (Millipore, Temecula, CA), mouse anti-SOX9 antibody (Sigma), and mouse anti-TGF-β1 14 
antibody (R&D Systems) under a fluorescence microscope, respectively. A bovine serum albumin 15 
solution without the primary antibody was used as a negative control. Alexa Fluor 568 phalloidin and 16 
Hoechst 33342 (Invitrogen, Carlsbad, CA) were used as a counter staining. 17 
Nuclear extraction, Western blot (WB), and immunoprecipitation (IP): Whole cell lysates, cytoplasmic 18 
fractions, and nuclear extracts of SW1353 cells were prepared as described (Furumatsu et al., 2009). 19 
Protein concentrations were measured by BCA protein assay kit (Bio-Rad, Hercules, CA). Equal 20 
amounts of proteins were applied (20 μg/lane). WB analyses were performed using anti-Smad2/3, 21 
anti-SOX9, and goat anti-phosphorylated Smad2/3 antibody (P-Smad2/3, Santa Cruz, Santa Cruz, CA) 22 
antibodies (1:1000 for 1 h). Cell extracts (1 x 106 cells) were prepared with IP buffer and then sonicated. 23 
Supernatants were incubated for 1 h with anti-SOX9 antibody (1:200) and protein G beads (Sigma). IP 24 
fraction was assessed by WB using an anti-P-Smad2/3 antibody. 25 
Luciferase reporter assay: SW1353 cells were seeded on type I collagen-coated stretch chambers (1 cm2). 26 
7 
 
Reporter plasmid pTS589, which contains the human CCN2 promoter (ranged from -802 to +22 base 1 
pair), and Smad2/3 constructed in pcDEF3-FLAG(N) (100 ng each) were transfected using 2 
Lipofectamine 2000 (Invitrogen) (Furumatsu et al., 2005A, 2012). pRL-SV40 (10 ng, Promega, Madison, 3 
WI) was used as an internal control. Cells were cultured for 12 h in serum-free DMEM prior to CTS 4 
treatments (0.5 Hz, 5% strain, 2 h). Luciferase activities were analyzed using Dual-Luciferase Reporter 5 
Assay System (Promega). 6 
Chromatin immunoprecipitation (Chromatin IP): Chromatin IP assays were performed as described 7 
(Furumatsu et al., 2005A). SW1353 cells were starved on chambers for 12 h before stretching. CTS (0.5 8 
Hz, 5% strain) was performed for 2 h, and the sonicated cell lysates were suspended in nuclear lysis 9 
buffer. The 10% volume of supernatant was stocked as an input sample. The half of each remaining 10 
sample was incubated for 2 h with anti-Smad2/3 antibody and protein G beads. The remaining 11 
supernatant was incubated with mouse IgG and protein G beads as a control. Input fraction DNAs, DNA 12 
fragments immunoprecipitated with Smad2/3, and DNAs in IgG controls were purified. PCR reactions 13 
were performed using the following primer set and were allowed to proceed for 30 cycles. Primer sets; 14 
(-754F, -595R) and (-243F, -83R) for amplifying specific regions of the human CCN2 promoter 15 
(Furumatsu et al., 2012), (-723F, -558R) and (+2311F, +2465R) to amplify specific regions of the human 16 
COL2A1 promoter and enhancer (Matsumoto et al., 2012). 17 
Enzyme-linked immunosorbent assay (ELISA): The concentration of TGF-β1 in conditioned media was 18 
measured by Quantikine ELISA human TGF-β1 immunoassay kit (R&D Systems). SW1353 cells seeded 19 
on chambers were maintained in FBS-free DMEM for 12 h. CTS treatment (0.5 Hz, 5% strain) was 20 
performed for an indicated duration (15, 30, 60, and 120 min). Each conditioned medium was collected 21 
for TGF-β1 ELISA. 22 
CCN2 treatment and cell proliferation assay: Cells were cultured on type I collagen-coated plates for 12 23 
h in serum-free DMEM before the treatment with recombinant human CCN2 (BioVender, Candler, NC). 24 
CCN2 was added into serum-free DMEM at indicated concentrations (1, 10, 50, and 100 ng/mL). Cells 25 
(5,000 cells/well) were incubated for 48 h prior to the addition of a cell proliferation reagent, water 26 
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soluble tetrazolium (WST)-1 (Roche Diagnostics), on 96-well plates. Optical density (OD) was measured 1 
at evaluation and control wavelengths of 450 nm and 630 nm, respectively. Data obtained by subtracting 2 
630-nm readings from 450-nm readings were used for evaluation (n = 5). For PCR analysis, CCN2 3 
treatment (10 and 50 ng/mL) was performed for 4 h before the preparation of RNA samples. 4 
Statistical analysis: Quantitative real-time PCR (4 reactions for each cDNA sample), 5 
immunohistochemistry (3 chambers for each detection), Western blot (2 membranes per each whole cell 6 
lysate), luciferase assay (5 chambers for each group), ELISA (5 wells per each sample), and proliferation 7 
assay (5 wells for each treatment) were repeated at least three times independently and similar results 8 
were obtained. Chromatin IP analysis was repeated four times. Data were expressed as means with 9 
standard deviations. Mean values were compared with a one-way ANOVA. Post hoc comparisons were 10 
performed using the Tukey test. Significance was set at p < 0.05. 11 
 12 
Results 13 
Mechanical stretch stimulates gene expression of CCN2 and COL2A1 in chondrocytic cells 14 
CTS treatments increased CCN2 expression in SW1353 cells up to a 1.7-fold level of unstretched 15 
controls (Fig. 1A, 4 h). In addition, COL2A1 gene expression was enhanced up to a 2.1-fold level of 16 
controls by 4-h CTS in SW1353 cells (Fig. 1B). However, expression of the master chondrogenic 17 
transcription factor SOX9 was not significantly increased in stretched SW1353 cells (Fig. 1C). 18 
Mechanical stretch increases protein production of CCN2 and induces nuclear translocalization of 19 
Smad2/3 and SOX9 in chondrocytic cells 20 
CCN2 deposition in the cytoplasm of SW1353 cells was stimulated by CTS (Fig. 2A). CTS induced 21 
nuclear translocalization of Smad2/3 and SOX9 in SW1353 cells (Fig. 2A). Total amounts of endogenous 22 
Smad2/3 and SOX9 were not influenced by 2-h CTS treatment (Fig. 2B). However, Smad2/3 localized to 23 
the nucleus was increased by CTS (Fig. 2C). In addition, IP analyses revealed that CTS increased the 24 
complex formation between phosphorylated (or activated) Smad2/3 and SOX9 in the nuclear fraction of 25 
stretched SW1353 cells (Fig. 2C).  26 
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Mechanical stretch and Smad3synergistically activate the CCN2 promoter in chondrocytic cells 1 
CTS treatment (2 h) enhanced the luciferase activity of the human CCN2 promoter-containing pTS589 in 2 
SW1353 cells (Fig. 3A). In addition, transient transfection of Smad2 increased relative luciferase activity 3 
compared with untransfected controls (Fig. 3A). However, CTS did not influence the pTS589 activity of 4 
Smad2-transfected cells (Fig. 3A). On the other hand, Smad3 transfection and CTS cooperatively 5 
enhanced the activity of pTS589 up to a 2-fold level of control (Fig. 3A). 6 
Mechanical stretch promotes Smad2/3 association with the CCN2 promoter and the COL2A1 enhancer 7 
in chondrocytic cells 8 
Chromatin IP analysis revealed that CTS treatment increased the association between endogenous 9 
Smad2/3 and the Smad-binding element located at the CCN2 promoter 2 in SW1353 cells (Fig. 3B). 10 
PCR fragment derived from the CCN2 promoter 2 was increased in the chromatin IP fraction using an 11 
anti-Smad2/3 antibody under 2-h stretched condition (Fig. 3B). The CCN2 promoter 1 that did not 12 
contain the Smad-binding element was not amplified in chromatin IP analysis (Fig. 3B). In addition, CTS 13 
increased the association between Smad2/3 and the COL2A1 enhancer on chromatin in SW1353 cells 14 
(Fig. 3C). In stretched cells, DNA fragment that contained the COL2A1 enhancer was 15 
coimmunoprecipitated with Smad2/3, probably via complex formation among Smad2/3-SOX9-the 16 
SOX9-binding site, and was amplified by PCR using specific primers for the COL2A1 enhancer (Fig. 17 
3C). However, no amplicon of the COL2A1 promoter was observed in SW1353 cells even under a 18 
stretched condition (Fig. 3C). 19 
Mechanical stretch induces TGF-β1 secretion in chondrocytic cells 20 
TGF-β1 was secreted from stretched SW1353 cells in a time-dependent manner (Fig. 4A). The 21 
concentration of secreted TGF-β1 reached a mean of 22.7 pg/mL in serum-free conditioned media of 22 
2-h-stretched cells (Fig. 4A). TGF-β1 concentration was increased up to 1.9- and 2.5-fold levels of 23 
unstretched control by 60- and 120-min CTS, respectively (Fig. 4A). In addition, the cytoplasmic 24 
deposition of TGF-β1 was decreased in SW1353 cells stretched for more than 60 min (Fig. 4B). 25 
CCN2 stimulates chondrocytic cell proliferation and COL2A1 expression 26 
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CCN2 treatments (10, 50, and 100 ng/mL) stimulated the proliferation of SW1353 cells (Fig. 5A). In 1 
addition, recombinant CCN2 increased COL2A1 expression up to a 1.8-fold level of untreated control 2 
(Fig. 5C). However, neither endogenous CCN2 nor SOX9 gene expression was influenced by 48-h 3 
CCN2 treatment (Fig. 5B and D). 4 
 5 
Discussion 6 
Cellular responses to mechanical stress underlie many critical functions such as development, 7 
morphogenesis, and wound healing. In experimental studies, physiological force has been mimicked by 8 
various mechanical stimuli, including stretch, compression, shear stress, and bending torque (Orr et al., 9 
2006). Cell stretch would induce mechanical extension of cytoplasmic macromolecules, activation of ion 10 
channels, and phosphorylation of mechanotransducers (Orr et al., 2006). However, cellular behavior is 11 
not uniform under comparable stretching condition in vitro. CCN2 expression is increased by cyclic 12 
stretch (no more than 15% strain) in bladder smooth muscle cells and chondrocytic cells (Nishida et al., 13 
2008; Yang et al., 2008). On the other hand, 20% length of cellular stretch rather decreases CCN2 14 
expression in skin fibroblasts (Kanazwa et al., 2009). In our experiments, 5% strain of stretching force 15 
stimulated gene expression of CCN2 and COL2A1 in chondrocytic cells (Fig. 1). In addition, 16 
recombinant CCN2 treatment stimulated cellular proliferation and COL2A1 expression (Fig. 5). Our 17 
results suggest that the syntheses of CCN2 and cartilaginous ECM molecules are induced under a 18 
physiological stretching force (< 10% strain) and by a stretching frequency showing a slow gait pattern 19 
(0.5 Hz) (Oberg et al., 1993; Shirazi et al., 2008). Considering the molecular property of CCN2 that 20 
promotes physiological process of tissue development and regeneration under multiple molecular 21 
interactions, mechanical stretch has more important roles in furnishing the microenvironment that 22 
supports type II collagen production and cartilage homeostasis. In our previous studies, CTS (0.5 Hz, 23 
5-10% strain) does not influence COL2A1 expression in SW1353 chondrocytic cells cultured on 24 
fibronectin-coated stretch chambers (Tetsunaga et al., 2011). In addition, CTS increased expression of 25 
catabolic genes, such as MMP-3/13 and ADAMTS-4/5/9, in SW1353 cells and human articular 26 
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chondrocytes on fibronectin (Tetsunaga et al., 2011; Saito et al., 2013). Several authors have 1 
demonstrated that fibronectin, localized mainly in the articular surface, stimulated MMP production and 2 
induced proteoglycan leakage (chondrolysis) in chondrocytes and organ-cultured cartilage (Homandberg 3 
et al., 1992; Long et al., 2013). On the other hand, the attachment and growth of chondrocytes are 4 
superior in type I collagen-coated scaffolds rather than in uncoated scaffolds (Honda et al., 2003). 5 
Chondrocytes seeded on type I collagen sponges show higher COL2A1 expression than those in type II 6 
atelocollagen gels (Freyria et al., 2009). However, passaged chondrocytes cultured in type II collagen 7 
matrix exhibit better cartilaginous features than those in type I collagen matrix (Chiu et al., 2011). 8 
Further investigations will be required to understand differential effects of ECM molecules on 9 
chondrocytic cells. 10 
SOX9 is necessary for mesenchymal condensation and sequential chondrogenic differentiation. 11 
Several transcription partners such as Sox5/6, c-Maf, TRAP230, p300, Barx2, Smad3, PIAS, β-catenin, 12 
and Scleraxis/E47 can modify SOX9-dependent transcription in chondrogenesis and sex determination 13 
(Furumatsu and Asahara, 2010). Co-activator p300 acts as a bridging factor for connecting DNA-binding 14 
transcription factors to the transcriptional apparatus, and as a protein scaffold to form multicomponent 15 
transcriptional complexes. We have previously reported that the histone acetyltransferase activity of 16 
p300 facilitates SOX9-dependent transcription on chromatin by histone modification (Furumatsu and 17 
Ozaki, 2010). COL2A1 transactivation on chromatin is directly regulated by the epigenetic function of 18 
SOX9-related transcriptional complex, which is composed of SOX9, Smad3, and p300. In the present 19 
study, CTS increased nuclear translocation of SOX9 and Smad2/3 in chondrocytic SW1353 cells (Fig. 20 
2A). In addition, CTS enhanced the complex formation between SOX9 and Smad2/3 without increasing 21 
total amounts of SOX9 and Smad2/3 (Fig. 2B and C), and stimulated association of Smad2/3 with 22 
COL2A1 enhancer, probably mediated by SOX9, on chromatin (Fig. 3C). Dynamic compression load 23 
also increases the nuclear translocation and phosphorylation of SOX9 in hydrogel-embedded human 24 
articular chondrocytes (Haudenschild et al., 2010). These findings suggest that mechanical stretch 25 
epigenetically regulates COL2A1 expression in chondrocytic cells via structural change of SOX9-related 26 
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transcriptional complex on chromatin (Fig. 6). Although Smad2 forms a complex with SOX9 in a 1 
manner similar to Smad3, COL2A1 expression induced by SOX9/Smad2 is lower than that by 2 
SOX9/Smad3 (Furumatsu et al., 2005A). Co-activator p300 stimulates Smad-dependent transactivation 3 
by binding to the MH2 domain of Smads and shows stronger affinity against Smad3 rather than Smad2 4 
(Pouponnot et al., 1998). In our studies, CTS-dependent up-regulation of the CCN2 promoter was 5 
enhanced by Smad3, but was not by Smad2, in SW1353 cells (Fig. 3A) and inner meniscus cells 6 
(Furumatsu et al., 2012). We consider that the distinct function between Smad2 and Smad3 in 7 
chondrogenesis may depend on their abilities to associate with p300 and to stabilize SOX9/p300 8 
transcriptional complex. Further examinations that investigate Smad/p300-mediated histone acetylation 9 
will be required to evaluate the precise role of Smad2/3 in response to mechanical stretch. 10 
The TGF-β ligands bind to a heteromeric TGF-β receptor complex consisting of two type I and 11 
two type II serine/threonine kinase receptors (Ross and Hill, 2008). The constitutively active type II 12 
receptor phosphorylates the type I receptor that phosphorylates the intracellular mediators of the TGF-β 13 
signaling pathway, the receptor-regulated Smads (R-Smads) including Smad2/3 (Fig. 6). In this study, we 14 
demonstrated that CTS induced TGF-β1 release and nuclear translocation of Smad2/3 in chondrocytic 15 
cells (Fig. 2 and 4). However, it is unclear whether the phosphorylation of Smad2/3 is directly induced 16 
by stretch-released TGF-β1 alone in our experiments. Phosphatase activity in the nucleus can remove the 17 
C-terminal phosphate from the active R-Smads and unphosphorylated inactive R-Smads constantly 18 
shuttle between the nucleus and cytoplasm (Ross and Hill, 2008). The activation of TGF-β receptor 19 
complex is also influenced by the inhibitory Smads (I-Smads), E3-ligases, and Smad anchor for receptor 20 
activation (SARA). In addition to the Smad2/3 pathway, TGF-β activates the mitogen-activated protein 21 
kinase (MAPK) pathway, which stimulates expression of COL2A1 and SOX9, during chondrogenesis 22 
(Tuli et al., 2003). The small GTPase Rac supports the activation of MAPK pathway and regulates the 23 
formation of focal adhesion complexes associated with lamellipodia (Burridge and Wennerberg, 2004). 24 
Rac1 also stimulates CCN2 expression via TGF-β/Smad signaling pathway in mouse primary 25 
chondrocytes isolated from E15.5 long bones (Woods et al., 2009). These findings suggest that the other 26 
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mechanisms such as the I-Smads, SARA, MAPK, and Rac1 may have distinct roles in modulating 1 
stretch-dependent Smad2/3 activation in chondrocytic cells. We consider that the Rho family GTPases 2 
(RhoA, Rac1, and Cdc42) involved in organizing the actin cytoskeleton might have an important role in 3 
modulating Smad-dependent expression of CCN2 and COL2A1 during chondrogenesis. In our study, 4 
pTS589-derived luciferase activity did not show a dramatic change (Fig. 3A). The human CCN2 5 
promoter-constructed pTS589 (from -802 to +22 base pair) includes many protein-binding sequences 6 
such as SBE, AP-1, SP-1, and TRENDIC (Eguchi et al., 2001 and 2008). pTS589 shows a 12-fold 7 
increase of luciferase activity compared with pDS4, which contains a shorter region of the CCN2 8 
promoter (from -88 to +22 base pair, lacking SBE). However, TGF-β1 stimulation induces only 30% 9 
increase of pTS589 activity in chondrocytic HCS-2/8 cells (Eguchi et al., 2001). These findings suggest 10 
that TGF-β-Smad pathway has a critical role in stimulating CCN2 gene expression but the 11 
TGF-β-Smad-dependent up-regulation of the CCN2 promoter may require a cooperative interaction of 12 
the other factors to induce full activation of the CCN2 promoter. Our results would be useful to prepare 13 
un-dedifferentiated chondrocytes and better tissue-engineered cartilage for regeneration therapy in 14 
cartilage injury and osteoarthritis. However, the comparative study using primary articular chondrocytes 15 
will be required to assess a complicated role of tensile strain in chondrocyte homeostasis. 16 
In conclusion, we demonstrate that mechanical stretch epigenetically stimulates CCN2 17 
transcription via TGF-β1 release associated with Smad2/3 activation and enhances COL2A1 expression 18 
through the complex formation between SOX9 and Smad2/3. Our results suggest that stretch-induced 19 
Smad2/3 activation may have a crucial role in regulating chondrogenesis. 20 
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Fig. 1. CTS stimulated gene expression of CCN2 and COL2A1 in chondrocytic SW1353 cells. In 1 
quantitative real-time PCR analyses, CTS treatments (0.5 Hz, 5% strain) increased CCN2 expression in 2 
SW1353 cells up to 1.5- and 1.7-fold levels of unstretched controls by 2-h and 4-h CTS, respectively (A). 3 
In addition, COL2A1 gene expression was enhanced up to a 2.1-fold level of controls by 4-h CTS in 4 
SW1353 cells (B). However, no significant increase of SOX9 expression was observed in stretched 5 
SW1353 cells (C). * p < 0.05. 6 
Fig. 2. CTS increased the deposition of CCN2 (A, green) in the cytoplasm of chondrocytic SW1353 cells. 7 
In addition, CTS induced nuclear translocalization of Smad2/3 (A, green) and SOX9 (A, green) in 8 
SW1353 cells. Controls in the absence of primary antibodies showed no signals. Double-headed arrows 9 
represent the direction of stretching. Red, F-actin. Bars, 25 μm. In Western blot (WB) analysis, CTS 10 
treatment (2 h) did not influence total amounts of endogenous Smad2/3 and SOX9 in each whole cell 11 
lysate (B, 20 μg/lane). However, Smad2/3 detected in the nuclear fraction was increased by CTS (C, 12 
Nucleus, 20 μg/lane). In IP analysis using an anti-SOX9 antibody, CTS increased the association between 13 
phosphorylated Smad2/3 and SOX9 in the nuclear fraction derived from stretched SW1353 cells (C, IP). 14 
Arrows indicate an expected size for each protein. 15 
Fig. 3. (A) CTS treatment (2 h) increased relative luciferase activity of pTS589, which contained the 16 
human CCN2 promoter, compared with a level of unstretched control in chondrocytic SW1353 cells. 17 
Smad2 transfection also stimulated pTS589 luciferase activity. No additional increase of the pTS589 18 
activity was observed in Smad2-transfected cells under stretched condition. On the other hand, Smad3 19 
and CTS synergistically enhanced the pTS589 activity up to a 2-fold level of control. * p < 0.05. (B) 20 
Chromatin IP analysis revealed that 2-h CTS treatment increased the association between Smad2/3 and 21 
the Smad-binding element located at the CCN2 promoter 2 in SW1353 cells. PCR fragment derived from 22 
the CCN2 promoter 2 was increased in the chromatin IP fraction using an anti-Smad2/3 antibody under a 23 
stretched condition (B, Promoter 2), compared with that in unstretched condition (B, Promoter 2). The 24 
CCN2 promoter 1 that did not contain the Smad-binding element was not amplified in chromatin IP 25 
analysis (B, Promoter 1). CTS also induced the association between Smad2/3 and the COL2A1 enhancer 26 
in SW1353 cells (C, Enhancer). The SOX9-binding site-free fragment was not detected in chromatin IP 27 
fraction (C, Promoter). Mouse IgG was used as the control for chromatin IP (IgG). Schemes involving 28 
18 
 
the promoters of human CCN2 and COL2A1 are shown (B and C). Gray box denotes the Smad-binding 1 
element on the CCN2 promoter (B). Filled box indicates the SOX9-binding site on the COL2A1 2 
enhancer (C). Numbers indicate the distance from the transcription start site of the CCN2 gene (GenBank, 3 
AF316366) and the COL2A1 (GenBank, AC004801). Arrowheads and dotted lines denote the primer sets 4 
and expected PCR fragments in chromatin IP, respectively (B and C). 5 
Fig. 4. CTS induced TGF-β1 secretion from stretched SW1353 cells in a time-dependent manner (A). 6 
The concentration of secreted TGF-β1 was 17.9 and 22.7 pg/mL in serum-free conditioned media of 60- 7 
and 120-min stretched cells, respectively (A). TGF-β1 concentration of unstretched cells was a mean of 8 
9.3 pg/mL (A). * p < 0.05. TGF-β1 was evenly distributed in the cytoplasm under a CTS-free condition 9 
(B, green). However, the cytoplasmic deposition of TGF-β1 was decreased in SW1353 cells stretched for 10 
60 and 120 min (B). Control in the absence of an anti-TGF-β1 antibody showed no signal. Blue, Hoechst 11 
staining. Bars, 25 μm. 12 
Fig. 5. Recombinant CCN2 treatment (48 h) stimulated the proliferation of SW1353 cells (A; 10, 50, and 13 
100 ng/mL). * p < 0.05. In real-time PCR analysis, CCN2 increased COL2A1 expression up to a 1.8-fold 14 
level of untreated control (C, 50 ng/mL). On the other hand, CCN2 did not influence endogenous gene 15 
expression pattern of CCN2 and SOX9 in SW1353 cells (B and D).  16 
Fig. 6. Schematic illustration of mechanical stretch-mediated responses in chondrocytic cells. (A) In the 17 
absence of stretching force, sufficient amounts of SOX9, TGF-β1, and Smad2/3 are stored in the 18 
cytoplasm of chondrocytic cells. Gene expression of COL2A1 and CCN2 is maintained, but not 19 
excessively up-regulated, under unstretched condition. (B) Physiological stretching force induces 20 
TGF-β1 secretion from the cytoplasm of chondrocytic cells. Extracellular TGF-β1 would stimulate 21 
membrane-bound TGF-β receptors in an autocrine (or paracrine) fashion. Then, the nuclear 22 
translocalization of TGF-β receptor-regulated Smad2/3 is activated. In addition, mechanical stretch 23 
induces the nuclear translocalization of SOX9. Phosphorylated (P) Smad2/3 and SOX9 cooperatively 24 
enhance COL2A1 expression under stretched condition. CCN2 gene expression is also activated by 25 
nuclear translocated Smad2/3 in chondrocytic cells. Stretch-induced CCN2 would stimulate chondrocytic 26 
cell proliferation and COL2A1 expression. 27 
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